News

Category:

July 30th, 2026

Updated: Home Dialysis Utility Reimbursement Calculator (2026)

The latest version of the Home Dialysis Utility Reimbursement Calculator is now available, reflecting utility tariffs for July 2026 to March 2027.

UKKA

July 29th, 2026

UKKA calls for flexible approach to rare disease therapies

The UK Kidney Association (UKKA) and the British Association for Paediatric Nephrology (BAPN) have submitted a joint response to the Medicines and Healthcare products Regulatory Agency (MHRA) consultation on its proposed Rare Disease Therapies Regulatory Framework, reflecting the views of the wider kidney community.

UKKA

July 27th, 2026

Avacopan update 24/07/26

Vifor, which markets avacopan in the UK, has issued a safety communication, in agreement with the MHRA, advising that no new patients should be started on the medicine while the MHRA review is ongoing.

UKKA

July 24th, 2026

Latest kidney centre data now available through UKRR portals

The UK Renal Registry (UKRR) has updated its Centre Summaries and Audit Standards portals with the latest verified kidney replacement therapy (KRT) data.

UK Renal Registry

Prime Minister greeting Health Secretary

July 21st, 2026

New Health Secretary urged to prioritise kidney disease

The UK Kidney Association has joined Kidney Care UK, Kidney Research UK, the National Kidney Federation and PKD Charity in writing to Yvette Cooper, the new Secretary of State for Health and Social Care.

Policy UKKA

UKRPG Sustainability Working Group description

July 10th, 2026

National dialysis initiative shortlisted for Patient Safety Award

The DAYLife Shared Haemodialysis Care Mentoring Programme has been shortlisted for the HSJ Patient Safety Awards 2026 in the Patient Safety Education and Training Award category.

DAYLife Haemodialysis KQIP

July 8th, 2026

New Cardiovascular Framework Strengthens Case for Kidney Disease

The UKKA welcomes the publication of the Government's new Cardiovascular Disease Modern Service Framework (MSF), in which chronic kidney disease (CKD) is included as an under-recognised contributing factor.

CKD UKKA

July 8th, 2026

Update on avacopan following regulatory developments

National clinical leaders for renal and rheumatology services have published an agreed interim position on the use of Tavneos® (avacopan) while the MHRA completes its review.

UKKA UKRPG

July 2nd, 2026

Supportive Care SIG welcomes new Chair

The UKKA is pleased to announce the appointment of Professor Helen Hurst as the new Multi-Professional Team Co-Chair of the Supportive Care Special Interest Group.

Supportive Care UKKA